ENTYVIO sous-cutanée 108 mg/0.68ml ser préremp
7680675370016
CH-67537
L04AG05
07.15.0.
Active substances:
1 / 3
google
Details
- Product number
- 6753701
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- vedolizumabum 108 mg, acidum citricum monohydricum, natrii citras dihydricus corresp. natrium 1.11 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.68 ml.
Articles (1)
Entyvio subkutan 108 mg, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
vedolizumabum
|
108.0 MG | Substance | Wirkstoff (Principe actif) |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
natrium
|
1.11 MG | Substance | HBESI |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
arginini hydrochloridum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 608.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2021
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 67537
- Drug name
- Entyvio subkutan, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AG05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 16/10/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ENTYVIO sous-cutanée 108 mg/0.68ml ser préremp
- Description (DE)
- ENTYVIO subkutan 108 mg/0.68ml Fertigspritze
- Market launch
- 16/10/2020
- Narcotic (BTM)
- No